Drapac invests extensively in developing the Drapac® pipeline of health-promoting products made from natural raw materials. These innovative products represent Drapac’s unique Intellectual Property. To support Drapac’s own innovation capability, the company is hosting world-class scientists to carry out research and product development in collaboration with universities and research institutes in New Zealand and overseas. We thank all New Zealand tax payers for significant amount of New Zealand Government Funding supporting Drapac Research and Development.
Quality policy & Development
Drapac pipeline products are made in world-class manufacturing facilities with premium quality ingredients. Drapac guarantees the quality of all of Drapac products
Drapac invests extensively in developing the Drapac® pipeline of health-promoting products made from natural raw materials. These innovative products represent Drapac’s unique Intellectual Property. To support Drapac’s own innovation capability, the company is hosting world-class scientists to carry out research and product development in collaboration with universities and research institutes in New Zealand and overseas. We thank all New Zealand taxpayers for significant amount of New Zealand Government Funding supporting Drapac Research and Development.
PUBLICATIONS RELATED TO DRAPAC PRODUCTS
Bian, L., Molan, A. L., Maddox, I., & Shu, Q. (2011). Antimicro- bial activity of Lactobacillus reuteri DPC16 supernatants against selected food borne pathogens. World Journal of Microbiology & Biotechnology, 27(4), 991-998.
Chen S. (2007) Modeling the Cellular Integrity of Microencapsu- lated and Freeze-dried L. reuteri DPC16 and Optimizing Proces-sing Factors for Longer Shelf-life Master Thesis, Medical and He- alth Science, University of Auckland, Auckland, New Zealand
Bian L. (2008) An in vitro antimicrobial and safety study of Lact- obacillus reuteri DPC16 for validation of probiotic concept. Mas- ters Thesis, School of Engineering and Advanced Technology, Massey University, Auckland, New Zealand
Lu, G. (2007). A novel approach for controlling foodborne path- ogens using modified atmosphere and Lactobacillus reuteri DPC 16. PhD of Food Science Thesis. Massey University, Auckland, New Zealand.
Bian, L. (2008). An in vitro antimicrobial and safety study of L- actobacillus reuteri DPC16 for validation of probiotic concept. Master of Science Thesis. Massey University, Auckland, New Z- ealand.
Tian, H., Maddox, I., Ferguson, L., & Shu, Q. (2010). Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals, 23(3), 593-596.
Chen S, Ferguson LR, Shu Q, Garg S. The application of flow c- ytometry to the characterisation of a probiotic strain Lactobacil- lus reuteri DPC16 and the evaluation of sugar preservatives for its lyophilization. LWT - Food Science and Technology. 2011;44: 1873-9. [doi:10.1016/j.lwt.2011.05.006]
Liu A., Duan E., Duan Y., Chen S., Wu J., Shi X., Nagarwala A., Joshi M., Gao Y.H., Chen X.D. & Shu Q. (2004c) Health-promot- ing properties of Probiopolis: Reduces the severity of Salmonella typhymurium infection in mice. Paper presented at the Microbes Outside the Square, Palmerston North, New Zealand.
Chen S, Zhao Q, Ferguson LR, Shu Q, Weir I, Garg S. Develop- ment of a novel probiotic delivery system based on microenca- psulation with protectants. Applied Microbiology and Biotechno- logy. 2012;93:1447-57. [doi:10.1007/s00253-011-3609-4]
Zhao, Q., Mutukumira, A. N., Lee, S. J., Maddox, I., & Shu, Q. (2011)Functional properties of free and encapsulated Lactobac- illus reuteri DPC16 during and after passage through a simulat- ed gastrointestinal tract. World Journal of Microbiology and Bio- technology, doi:10.1007/s11274-011-0792-5.
Chen S, Cao Y, Ferguson LR, Shu Q, Garg S. Flow cytometric a- ssessment of the protectants for enhanced in vitro survival of probiotic lactic acid bacteria through simulated human gastro- intestinal stresses. Applied Microbiology and Biotechnology. 201 2;95:345-56. [doi: 10.1007/s00253-012-4030-3]
Liu A., Duan E., Duan Y., Chen S., Wu J., Shi X., Nagarwala A., Joshi M., Gao Y.H., Chen X.D. & Shu Q. (2004b) Health-promot- ing properties of Probiocaps: Enhances resistance to Rotavirus Infection in mouse and piglet models. Paper presented at the Microbes Outside the Square, Palmerston North, New Zealand.
Chen S, Cao Y, Ferguson LR, Shu Q, Garg S. The effect of imm- obilization of probiotic Lactobacillus reuteri DPC16 in sub-100 μm microcapsule on food-borne pathogens. World Journal of Microbiology and Biotechnology. 2012;28:2447-52. [doi: 10.10 07/s11274-012-1046-x]
Tian H., Maddox I.S., Ferguson L.R. & Shu Q. (2010a) Evaluati- on of the cytoprotective effects of bovine lactoferrin against int- estinal toxins using cellular model systems. Biometals 23, 589- 92. Bibliography 181.
Chen S, Cao Y, Ferguson LR, Shu Q, Garg S. Evaluation of mu- coadhesive coatings of chitosan and thiolated chitosan for the colonic delivery of microencapsulated probiotic bacteria. 2012; Epub ahead of print. [doi: 10.3109/02652048.。。]
Tian H., Maddox I.S., Ferguson L.R. & Shu Q. (2010b) Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals 23, 593-6.
Chen S, Shu Q, Liu A, Riddle P, Ferguson LR, Garg S. Modelling the cellular integrity of microencapsulated and lyophilised Lact- obacillus reuteri DPC16 and optimising processing parameters for enhanced cell viability. HealtheX 2008 Conference. 12th Se- ptember 2008, Auckland, New Zealand.
Zhao Q., Lee S.J., Mutukumira A.N., Maddox I. & Shu Q. (2011) Viability and delivery of immobilised Lactobacillus reuteri DPC16 within calcium alginate gel systems during sequential passage through simulated gastrointestinal fluids. Benef Microbes 2, 129 -38.
Chen S, Tian H, Ferguson LR, Shu Q, Garg S. Characterisation of a novel probiotic strain – Lactobacillus reuteri DPC16. APSA 2008 Conference. 6th-9th December 2008, Canberra, Australia.
Shu Q. & Liu A. (2008) Lactobacillus reuteri DPC16. N.Z. Patent No 526544. New Zealand Intellectual Property Database Extract, New Zealand Intellectual Property Office.
Chen S, Ferguson LR, Garg S, Shu Q. Application of flow cytom- etry to the characterisation of stress resistance of the probiotic strain Lactobacillus reuteri DPC16 and evaluation of sugars as preservative for this strain to survive lyophilisation. NZBIO Co- nference 2010. 22nd-24th March 2010, Auckland, New Zealand.
Liu A., Chen S., Duan E., Wu J., Shi X., Nagarwala A., Joshi M., Gao Y.H., Chen X.D. & Shu Q. (2004a) Health-promoting prope- rties of probiotics-colostrums: Enhances non-specific and speci- fic immune responses in mice challenged with Escherichia coli O 157:H7. Paper presented at the Microbes Outside the Square, Palmerston North New Zealand. Bibliography 172
Drapac A Leading New Zealand Healthcare Brand ©1999. All rights reserved
   PRODUCTS |  ENTITY |  PARTNERSHIP |  QUALITY POLICY |  HEALTH LIBRARY |  CONTACT US